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Crude extracts of Chresta exsucca were investigated for their in
vitro trypanocidal, leishmanicidal, antibacterial and antifungal
activities. Trypomastigote forms of Trypanosoma cruzi,
amastigote-like forms of Leishmania amazonensis and twenty strains
of microorganisms including Gram-positive and Gram-negative
bacteria and yeasts were utilized in the bioassays. The best results
were found for the leishmanicidal activity. The chemical composition
of hexanic and ethanolic extracts of this species was determinate
using chromatographic techniques as HRGC and HPLC-ESI-MS,
respectively. Steroids, triterpenes and flavonoids were identified.
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INTRODUCTION
The use and research of natural products have
increased in the last years because of the biological
activities of their constituents, including the studies
performed with plants species for treatment of parasitic
and microbial diseases (Kayser et al., 2003a; Newman et
al., 2003; Truiti et al., 2003; Oumzil et al., 2002).
In South America, the Chagas disease is a public health
problem and represents the first cause of cardiac lesions in
young and economically productive adults (Moncayo, 2003).
Nearly 20 million people are infected by Trypanosoma cruzi
while 90 million are at risk in endemic areas (WHO, 1991,
2000). The transmission of the disease occurs mainly by the
vector (Triatomine), blood transfusion and congenital routes
(Coura, Castro, 2002). There is no satisfactory chemotherapy
for the disease in any of its phases. The scarcity of serological
control for blood donors in endemic areas and the restricted
alternative of chemoprophylaxis using gentian violet, have
caused a need to the development of new drugs against this
disease (Araya et al., 2003; WHO, 2000).
Other problem that occurs in South America is the
leishmaniases that comprise a group of cutaneous,
mucocutaneous and visceral diseases caused by
haemoflagellate protozoan parasites that survive and
multiply in macrophages in the mammalian host and are
transmitted by phlebotomine sandflies (WHO, 2000; Bara-
ta et al., 2000; WHO, 1990). The incidence of this disease
has increased in the last years and therapy available mainly
include antimonials, pentamidine and amphotericin B, which
are toxic, difficult to apply in the field and not always
effective (Peters, 1999; Thakur et al., 1999).
In addition, the development of resistant strains of
pathogenic bacteria to antibiotics currently in use in the
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therapeutic is a problem of continuing concern to public
health (Karaman et al., 2003).
Asteraceae family comprises many species with
antimicrobial and antiprozoal activities, such as, for
example, Lychnophora staavioides (Takeara et al.,
2003) and Podolepsis hieracioides (Kayser et al.,
2003b). The genus Chresta, belonging to this family,
comprises 12 endemic species from Brazilian Central
Plateau (Robinson, 1999). Chresta exsucca is perenial
herbs adapted to the arid conditions of shrubby “cerrado”
and is known principally from the state of Goiás
(MacLeish, 1985). Here we report for the first time the
biological activity of crude extracts from C. exsucca
against two protozoan parasites (Trypanosoma cruzi
trypomastigotes and Leishmania amazonensis
amastigotes) and several strains of bacteria and fungi.
The chemical composition of bioactive hexanic and
ethanolic extracts was also determined by
chromatographic analysis (HRGC and LC-ESI-MS).
MATERIALS AND METHODS
Plant material
Chresta exsucca was collected in Alto do Paraíso
(GO-Brazil) in October 1998 and identified by Dr. João
Semir (Instituto de Biologia, Unicamp, Campinas, SP-Bra-
sil). A voucher specimen is deposited in the Herbarium of
FFCLRP/USP (SPFR6873).
Preparation of plant extracts
Plant material (2100 g) was dried, pulverized and
stored in dark bags to protect them from humidity and light.
The powdered material was extracted by maceration with
n-hexane, dichloromethane and ethanol at room
temperature. The solvents used in each extraction were
evaporated under reduced pressure and different extracts
were obtained. These extracts were evaluated against
Trypanosoma cruzi trypomastigote forms, Leishmania
(L.) amazonensis amastigote forms, Gram-positive and
Gram-negative bacteria strains and yeasts. In addition, the
chemical composition of hexanic and ethanolic extracts
was determined by gas chromatography and HPLC-ESI-
MS, using standard, respectively.
Clean up procedure
An aliquot (10 mg) of the hexane extract was
resuspended in analytical grade chloroform (3 mL) and
percolated through a sep-kap column (Alltech, silica-gel
200 mg, 3 mL). The column was eluted with hexane
(10 mL) and chloroform (10 mL). Fractions were
collected separately and evaporated to dryness at room
temperature. Chloroform phase was analyzed by HRGC
in duplicate. The ethanolic extract (10 mg) was
resuspended in methanol-water (7:3) (3 mL) and
percolated through a sep-kap column (Alltech, C-18,
200 mg, 3 mL). The column was eluted with analytical
grade methanol (10 mL) and this phase was analyzed by
HPLC-ESI-MS.
Gas chromatographic analysis
Chloroform phase was analyzed by HRGC on a
Hewlett-Packard model 5890 Series II Gas Chroma-
tograph with a split injector (split ratio 1:60) at 260 oC and
a flame ionization detector at 330 oC. The injected volume
was 2 mL. Hydrogen was employed as carrier gas at an
average linear velocity of 44 cm/s (HP-50) and 42 cm/s
(HP-1). The HP-50 (cross-linked 50% phenyl-methyl-
silicone, 30 m x 0.25 mm x 0.25 mm) and HP-1 (cross-
linked methyl-silicone, 30 m x 0.25 mm x 0.25 mm) capillary
columns were employed. For HP-50 the column
temperature was 280 oC (isotherm) and for HP-1 the
column temperature program was 250 oC held for 12 min,
increased at 6 oC/min to 280 oC, and held this temperature
for 30 min. Data were processed on a Hewlett-Packard
model 3395 injector. The standards used in the gas
chromatography are listed in Table III.
HPLC-ESI-MS analysis
Ethanolic extract was analyzed by HPLC system
consisting of LC10AD solvent pumps, SLC10A system
controller, 7125 Rheodyne injector (Shimadzu, Japan),
Shim –Pack ODC-18 analytical column (4,6 x 250 mm)
with a RP-18 guard column (LiChrospher® 100,5 mm,
4 x 4 mm, Merck, Germany). An UV detector (SPD10A,
Shimadzu, Japan) set at 280 nm was used. The mobile
phase conditions were as follows: 15% MeOH at 0 min,
75% at 40 min, held constant until 45 min, 15% at 60 min.
The next sample was injected after a further 10 min. The
flow-rate was 1 mL min-1, at room temperature, and the
injection volume was 20 mL. The ESI-MS spectra were
acquired in a Quattro LC quadrupole mass spectrometer
fitted with a electrospray interface operating in the
negative ion mode (Micromass, United Kingdom). The
source and desolvation temperatures were 70 oC and
100 oC, respectively. Cone voltage was 30 V. The parent
ion and the retention time were compared with previously
isolated standards.
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In vitro trypanocidal activity
For the trypanocidal activity blood of Swiss albino
mice infected with T. cruzi (Y strain) was used. It was
collected by cardiac puncture at the peak of parasitemia
and was diluted to contain 106 trypomastigotes/mL. Stock
solutions (crude extracts) were prepared in 2.5% of
dimethyl sulfoxide (DMSO) and were added to blood
samples to provide a final concentration of 4000 mg/mL.
After incubation for 24 hours at 4 oC, the number of
parasites was determined according to Brener (1962). In
the tests, gentian violet (250 mg/mL) was used as positive
control and DMSO 2.5% as negative control. All
experiments were performed in triplicate.
In vitro leishmanicidal activity
Axenic L. (L.) amazonensis (strain designation
MPRO/BR/72/M 1841) amastigotes were serially
cultivated at 33 oC in modified UM-54 mediun (Pral et al.,
2003) and were used at the beginning of the stationary
phase. Washed parasites were resuspended in RPMI-1640
medium supplemented with 4% fetal calf serum, pH 5.0
and incubated at 33 oC for 24 hours with crude extracts
(1000 mg/mL) dissolved previously in RPMI-1640. As
controls, parasite suspensions were incubated in RPMI
alone or RPMI containing 0.1% DMSO. Amastigote
viability was assessed colorimetrically by reduction of a
tetrazolium salt (MTT) as described by Mosmann (1983).
Amphotericin B (20 mg/mL) was used as the positive
control and DMSO/RPMI-1640 (1:99) negative control.
The experiments were carried out in triplicate.
Antimicrobial activity
The effect of crude extracts was evaluated against
twenty strains of microorganisms, including Gram-positive
and Gram-negative bacteria and yeasts. The following
microorganisms were used: Escherichia coli – ATCC
10538; Pseudomonas aeruginosa – ATCC 27853; P.
aeruginosa – 290 D (field strain); Micrococcus luteus –
ATCC 9341; Staphylococcus aureus – ATCC 25923 and
6538; S. aureus 7+ penicilinase producer; S. aureus 8-
penicilinase non-producer; Staphylococcus epidermidis
6epi and epiC (field strain); Candida albicans – ATCC
1023; C. albicans cas and Candida tropicalis ct (field
strains), cultivated for 24 hours at 37 oC in Mueller Hinton
broth (Difco) – MHb; Enterococcus faecalis – ATCC
10541; Streptococcus mutans – ATCC 25175; S. mutans
(strains 11.1; 9.1; fab3; 11.2) and Streptococcus sobrinus
180.3 (field strains), incubated for 24 hours at 37 oC in
Brain Heart Infusion (Difco) – BHI. The standard and field
strains (oral cavity) were collected from “Departamento
de Análises Clínicas, Toxicológicas e Bromatológicas,
Faculdade de Ciências Farmacêuticas de Ribeirão Preto,
Universidade de São Paulo, Ribeirão Preto – SP, Brasil”.
Sensitivity tests were performed by a modified agar-well
diffusion method (well technique in double layer)
according to Okeke et al. (2001), Cole (1994), Grove,
Randall (1955). The Mueller Hinton Medium (Difco) - MH
agar plates, containing an inoculum size of
106 cfu/mL of Escherichia, Pseudomonas, Micrococcus,
Staphylococcus and Candida strains or 106 cfu/mL of
Enterococcus and Streptococcus strains on Brain Heart
Infusion Agar (Difco) – BHIa plates, were used. The
inoculum size of each test strain was standardized
according to National Committee for Clinical Laboratory
Standard (NCCLS, 1993). Subsequently, aliquots of 20 mL
of each test-drug solution were applied into 5.0 mm
diameter wells. Crude extract solutions were prepared at
5000 mg/mL in propyleneglycol/sterile water (5:95). After
incubation at 37 oC for 24 hours, the inhibition zone
corresponding to the halo (H) formed from well edge to the
beginning of the region of microbial growth was measured
in millimeters (mm). In the tests, bacitracine (0.2 UI/mL)
and ketoconazole (100 mg/mL) were used as positive
controls and propyleneglycol/sterile water (5:95) served as
negative control. The experiments were performed in
duplicate for each strains analyzed.
RESULTS AND DISCUSSION
The results of bioactivity of crude extracts from C.
exsucca for activity against T. cruzi trypomastigotes and
L. amazonensis amastigote-like stages are showed in
Table I. When examined against T. cruzi trypomastigotes,
hexanic extract from C. exsucca (total plant) given at 4000
mg/mL did not interfere appreciably with parasite viability,
whereas dichloromethanic and ethanolic extracts reduced
parasite viability to 46.7 and 49.2%, respectively. In these
assays mice infected blood containing 2.5% of DMSO
were used as negative control and did not interfere with T.
cruzi tryposmastigotes viability, while the gentian violet at
250 mg/mL were used as positive control and showed
100% of activity.
On the other hand, all the extracts evaluated interfe-
re markedly with viability of L. amazonensis amastigotes.
Hexanic, dichlorometanic and ethanolic extracts were
clearly leishmanicidal and parasite viability were reduced
to 1.8, 4.7 and 0.2%, respectively. Amphotericin B
(20 mg/mL), here used as a positive control, reduced
amastigote viability to 3.7%. Suspensions of L.
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amazonensis amastigotes incubated in medium alone or in
medium containing 0.1% DMSO remained viable during
the 24 h incubation period (% amastigote viability=100.0%),
a result that excludes spontaneous parasite damage during
the bioassay.
The extracts from C. exsucca were also screened
for antibacterial and antifungal activity and the results are
showed in Table II. While ethanolic extract was inactive
(at 5000 mg/mL) against all eighteen strains of
microorganisms tested, dichloromethanic extract was
effective against only strains the Streptococcus (three
strains of S. mutans and one strain of S. sobrinus) and
hexanic extract inhibited the growth of five strains
including S. aureus, S. mutans, S. sobrinus, E. coli and P.
aeruginosa. As indicated in Table II, the extracts of C.
exsucca assayed were ineffective against Candida strains
tested. Bacitracine at 0.2 UI/mL (against bacteria strains)
and ketoconazole at 100 mg/mL (against fungi strains), here
were used as positive controls, inhibited the growth of all
microorganism assayed. Media containing propyleneglycol/
sterile water (5:95) were used as negative control for
which no inhibitory effect was observed.
The biological activities of crude extracts from C.
exsucca are being evaluated for the first time and the
results obtained indicate the potential of this plant as a
source of bioactive compounds.
TABLE I - In vitro activity of crude extracts from Chresta
exsucca against Trypanosoma cruzi trypomastigotes and
axenic Leishmania amazonensis amastigotes
Extracts Antiprotozoal activitya
% viability of % viability of
T. cruzi L. amazonensis
trypomastigotes  amastigotes
Hexane 89.06 ± 0.64 1.83 ± 0.01
Dichloromethane 46.71 ± 1.67 4.72 ± 0.04
Ethanol 49.15 ± 1.46 0.28 ± 0.02
Amphotericin B
    (20 mg/mL)b - 3.70 ± 0.05
DMSO/RPMI-1640
    (1:99)c - 100.00 ± 0.02
Gentian violet
    (250 mg/mL) d 0.00 ± 0.00 -
DMSO (2.5%)e 100.00 ± 0.00 -
a = Results expressed as% viability (± standard deviation) of
the T. cruzi trypomastigotes (extracts evaluated at
4000 mg/mL) and L. amazonensis amastigotes (extracts
evaluated at 1000 mg/mL); b = positive control of the anti-
leishmanial assay; c = negative control of the antileishmanial
assay; d = positive control of the trypanocidal assay; e = mice
infected blood containing 2.5% of DMSO was used as
negative control of the trypanocidal assay; - = not done.
TABLE II - Antimicrobial activity of crude extracts from Chresta exsucca
Microorganisms A B C Bacitracine Ketoconazole
(0.2 UI/mL)a  (100 mg/mL)a
H H H H H
S. aureus (ATCC 6538)b - - - 23 -
S. aureus penicilinase + (7+)c 12 - - 25 -
S. aureus penicilinase – (8-)c - - - 25 -
S. epidermidis (6ep)c - - - 31 -
M. luteus (ATCC 9341)b - - - 25 -
E. faecalis (ATCC 10541)b - - - 28 -
S. mutans (ATCC 25175)b 9 8 - 24 -
S. mutans (fab3)c - - - 22 -
S. mutans (9.1)c - 10 - 22 -
S. mutans (11.1)c 8 8 - 22 -
S. mutans (11.2)c - - - 22 -
S. sobrinus (180,3)c - 7 - 23 -
E. coli (ATCC 10538)b 7 - - 32 -
P. aeruginosa (ATCC 27853)b 11 - - 22 -
P. aeruginosa (290D)c - - - 22 -
C. albicans (cas)c - - - - 30
C. albicans (ATCC 1023)b - - - - 30
C. tropicalis (ct)c - - - - 15
H = halo of inhibition (mm); - = absence of inhibition of microbial growth at 5000 mg/mL; A = hexane extract; B =
dichloromethane extract; C = ethanol extract; a: positive control; b = standard strains; c = field strains (oral cavity).
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Seeking to verify the chemical composition of the
bioactive crude extracts from C. exsucca, analysis
employing the chromatographic techniques HRGC and
HPLC-ESI-MS was proceeded.
Gas chromatography has been the traditional
technique for the analysis of terpenoids. Improved
technology in GC fused-silica capillary columns has
enabled the use of much shorter (<10 m) columns.
Several studies on the characterization of wood
extractives show that capillary GC is by far the most
convenient and comprehensive technique available for
separat ing the individual  components in wood
extractives (Vasconcelos et al., 2000; Fernandez et al.,
2001). To identify the triterpenes and sterols from
hexanic extract of C. exsucca, 26 authentic standards
were used. These standards were obtained from several
plant species, which were studied in our laboratory. In
Table III are summarized the HRGC results of the
sterols and triterpenes extracted and identified. These
structures were unequivocally confirmed by co-
injection of authentic standards and identified by
relative retention value.
HPLC-ESI-MS represents the combination of a
high-resolution separation system with a powerful
detection/characterization technique, which has been
successfully applied to the determination of compounds
present in material from a variety of natural product
source. A specific application of HPLC-ESI-MS natu-
ral product mixture analysis is the procedure known as
dereplication. This process is rapid, precise and
efficient besides has become one of the key processes
for maintaining samples from natural source (Strege,
1999). Lin et al. (2000) utilized the HPLC-ESI-MS
technique to detect the presence flavonoids in red
clover.
TABLE IV - Flavonoids identified by HPLC-ESI-MS in ethanolic extract of Chresta exsucca
Standards Rt (min) a [M-H]- (m/z)b Present flavonoids
Apigenin 16.86 269 +
Luteolin 16.22 285 +
Genkwanin 18.80 283 +
Crysoeriol 16.99 299 +
Velutin 18.74 313 -
Kaempferol 16.05 285 +
Tiliroside 15.53 579 -
Luteolin 3’-O-β-D-glucopyranoside 15.04 447 +
Luteolin 4’-O-β-D-glucopyranoside 13.51 447 +
Luteolin 7-O-β-D-glucopyranoside 9.17 447 +
Vicenin-2 11.37 593 +
Rta = retention time values; b [M-H]- = molecular íon; + = presente flavonoids; - = compound not detected
TABLE III - Triterpenes and sterols identified by HRGC
(HP-50 colunm) in hexanic extract of Chresta exsucca
Standards RRa Hexanic extract
% area
Campesterol 1238 -
Stigmasterol 1308 0.095
β-sitosterol 1453 -
D7-stigmastenol 1513 -
Spinasterol 1683 -
Taraxerone 1628 -
Epitaraxerol 1656 -
Taraxerol 1698 -
β-Amyrin 1768 0.165
α-Amyrin 1992 1.335
Lupeol 2052 1.080
β-Friedelanol 2491 -
Friedelin 2724 -
Pseudotaraxasterol 2479 -
Taraxasterol 2570 -
11-oxours-12-ene 3160 -
11-oxoolean-12-ene 3586 0.240
Taraxerol acetate 1872 -
β-amyrin acetate 1930 9.365
α-amyrin acetate 2154 29.640
Lupeol acetate 2234 30.335
Bauerenyl acetate 2508 -
11a,12a-oxidetaraxeryl acetate 2810 -
β-friedelanol acetate 2871 -
α-amyrinonil acetate 3653 8.615
β-amyrinonil acetate 4126 1.935
RRa = relative retention to cholesterol (internal standard);
-: compound not detected
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In order to verify the correct identification of the
present flavonoids in the ethanolic extract of C. exsucca,
11 standards, all obtained from C. scapigera (Schinor,
2004), were used. Standard solutions of flavonoids were
chromatographed to determine their retention times and
MS data for comparison with the chromatograms of the
plant extract. The results are showed in the Table IV.
Thus, the chemical composition of hexanic and ethanolic
extract from C. exsucca could be determined without the
need of isolation and purification processes of compounds
through classical phytochemistry, which involves methods that
are both costly and time-consuming. Steroids, triterpenes and
flavonoids were identified in crude extracts of C. exsucca.
Some of these compounds showed to be  active against
microorganisms (protozoal, bacteria and fungi) as reported
previously by the literature (Salvador et al., 2004; Schinor et
al., 2004; Taleb-Contini et al., 2003; Pena et al., 2001).
However, further biological studies should be performed,
including in vitro and in vivo investigations, as well as to
evaluation of the toxicity, looking toward a clinical employment
of these bioactive natural products.
CONCLUSION
Crude extracts of C. exsucca showed trypanocidal,
leishmanicidal and antibacterial in vitro activities. The
chemical composition of hexanic and ethanolic extracts
was determined using HRGC and HPLC-ESI-MS
chromatographic techniques. Steroids, triterpenes and
flavonoids were identified.
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RESUMO
Atividades biológicas e composição química dos
extratos brutos de Chresta exsucca
As atividades tripanocida, leishmanicida,
antibacteriana e antifungica dos extratos brutos de
Chresta exsucca  foram investigadas. Formas
tripomastigotas do Trypanosoma cruzi ,  formas
amastigotas de Leishmania amazonensis e vinte cepas
de microrganismos, incluindo bactérias Gram-positi-
vas, Gram-negativas e leveduras, foram utilizadas
nos ensaios biológicos. Os melhores resultados foram
obtidos para a atividade leishmanicida. A composi-
ção química dos extratos hexânicos e etanólicos des-
sa espécie foi determinada empregando-se técnicas
cromatográficas como HRGC e HPLC-ESI-MS, res-
pectivamente. Esteróides, triterpenos e flavonóides
foram identificados.
UNITERMOS: Chresta exsucca. Asteraceae. Atividades
biológicas. HRGC. HPLC-ESI-MS.
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